Trial
NCT04661540
A Study of Auxora in Patients With Critical COVID-19 Pneumonia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
CalciMedica, Inc.
Collaborators
Northwestern University
Condition
Pneumonia
Intervention
CM4620-IE (Injectable Emulsion)
Why stopped
The trial was terminated early due to the limited number of new COVID-19 hospitalizations.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-18